Gene Mack's Net Worth

-$144

Estimate Recalculated Sep 8, 2024 07:23PM EST

Who is Gene Mack?

Gene Mack does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SELLAS Life Sciences Group, Inc., and Gain Therapeutics, Inc..

SEC CIK

Gene Mack's CIK is 0001737979

Past Insider Trading and Trends

2024 was Gene Mack's most active year for acquiring shares with 2 total transactions. Gene Mack's most active month to acquire stocks was the month of March. 2024 saw Gene Mack paying a total of $14,544.00 for 214,400 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SELLAS Life Sciences Group, Inc. (SLS) Snapshot price: $1.16

CFO and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 20
Form 3
—
0
—
—
0
No matching records found

Gain Therapeutics, Inc. (GANX) Snapshot price: $1

CFO and Interim CEO

Gene Mack owns 14,400 units of Common Stock which is worth $14,400.00. In the year 2024 Gene Mack filed a total of 3 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
14.4K
$1.01
$14,544.00
14.4K
Aug 9
Form 4
—
0
—
—
0
Apr 8
Form 3
—
0
—
—
0
No matching records found